Cargando…
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
BACKGROUND: Guidelines recommend inhaled corticosteroids (ICS) for patients with severe chronic obstructive pulmonary disease (COPD). Most COPD patients are managed in primary care and receive ICS long-term and irrespective of severity. The effect of withdrawing ICS from COPD patients in primary car...
Autores principales: | Choudhury, Aklak B, Dawson, Carolyn M, Kilvington, Hazel E, Eldridge, Sandra, James, Wai-Yee, Wedzicha, Jadwiga A, Feder, Gene S, Griffiths, Chris J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245934/ https://www.ncbi.nlm.nih.gov/pubmed/18162137 http://dx.doi.org/10.1186/1465-9921-8-93 |
Ejemplares similares
-
Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology
por: Nadeem, Nighat J, et al.
Publicado: (2011) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016) -
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
por: Cazzola, Mario, et al.
Publicado: (2023) -
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)